Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatis

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2421-2432

  Yilma, Abebayehu N ^a   Singh, Shree R ^a   Dixit, Saurabh ^a   Dennis, Vida A ^a  

^a ALABAMA STATE UNIVERSITY   (United States)

Author keywords

Bacteria; Chemokines; Cytokines; NOD2; Sexually transmitted disease; Silver nanoparticles; TLR2

Indexed keywords

B7 ANTIGEN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CYTOKINE; GELATINASE B; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 6; MESSENGER RNA; POVIDONE; SILVER NANOPARTICLE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; DOWNSTREAM PROCESSING; DRUG CYTOTOXICITY; GENE EXPRESSION; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BACTERIA; CHEMOKINES; CYTOKINES; NOD2; SEXUALLY TRANSMITTED DISEASE; SILVER NANOPARTICLES; TLR2;

ANIMALS; ANTI-INFLAMMATORY AGENTS; B7 ANTIGENS; CELL LINE; CHLAMYDIA TRACHOMATIS; CYTOKINES; DRUG DELIVERY SYSTEMS; HOST-PATHOGEN INTERACTIONS; MACROPHAGES; METAL NANOPARTICLES; MICE; POVIDONE; SILVER;

EID: 84880092437     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Stephens RS. Challenge of Chlamydia research. Infect Agent Dis. 1993;1:279-293.
2. Bavoil PM, Hsia RC, Rank RG. Prospects for a vaccine against Chlamydia genital disease: microbiology and pathogenesis. Bull Inst Pasteur. 1996;94:50-54.
3. Schachter J, Dawson CR. The epidemiology of trachoma predicts more blindness in the future. Scand J Infect Dis. 1990;69:55-62.
4. Joseph TD, Bose SK. A heat labile protein of Chlamydia trachomatis binds to HeLa cells and inhibits the adherence of chlamydiae. Proc Nat Acad Sci U S A. 1991;88:4054-4058.
5. Swanson AF, Kuo CC. Binding of the glycan of the major outer membrane protein of Chlamydia trachomatis to HeLa cells. Infect Immun. 1994;62:24-28.
6. Ting LM, Hsia RC, Haidaris CG, Bavoil PM. Interaction of outer envelope proteins of Chlamydia psittaci GPIC with the HeLa cell surface. Infect Immun. 1995;63:3600-3608.
7. Su H, Raymond L, Rockey D, Fischer E, Hackstadt T, Aldwell HD. A recombinant Chlamydia trachomatis major outer membrane. Infect Immun. 1996;65:11134-11140.
8. Raulston JE, Paul TR, Knight ST, Wyrick PB. Localization of Chlamydia trachomatis heat shock proteins 60 and 70 during infection of a human endometrial epithelial cell line in vitro. Infect Immun. 1998;66:2323-2329.
9. Chamaillard M, Hashimoto M, Horie Y, etal. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol. 2002;4:702-707.
10. Girardin SE, Boneca IG, Carneiro LA, etal. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science. 2003;300:1584-1587.
11. Inohara N, Ogura Y, Fontalba A, etal. Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn's disease. J Biol Chem. 2003;278:5509-5512.
12. Girardin SE, Boneca IG, Viala J, etal. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869-8872.
13. Stephens RS. The cellular paradigm of chlamydial pathogensis. Trends Microbiol. 2003;11:44-51.
14. Kuo CC. Host response. In: Barron AL, editor. Microbiology of Chlamydia. Boca Raton: CRC press; 1988:193-208.
15. Taylor HR. An animal model of trachoma II. The importance of repeated re-infection. Invest Ophthalmol Vis Sci. 1982;23:507-515.
16. Patton DL, Taylor HR. The histopathology of experimental trachoma: ultrastructural changes in the conjunctival epithelium. J Infect Dis. 1986;153:870-878.
17. Skilton RJ, Cutcliffe LT, Barlow D, etal. Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the development cycle. PLoS One. 2009;4:e7723-e7723.
18. Bain DL. Chlamydial genovar distribution after community wide antibiotic treatment. J Infect Dis. 2001;184:1581-1588.
19. Yilma AN, Singh SR, Fairley SJ, Taha MA, Dennis VA. The anti-inflammatory cytokine, interleukin-10, inhibits inflammatory mediators in human epithelial cells and mouse macrophages to live and UV-inactivated Chlamydia trachomatis. Mediators Inflamm. 2012;2012:520174.
20. Byrne GI, Faubion CL. Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon. Infect Immun. 1983;42:1152-1158.
21. Beatty WL, Morrison RP, Byrne GI. Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect Immun. 1995;63: 199-205.
22. Hoyme UB. Clinical significance of Crede's prophylaxis in Germany at present. Infect Dis Obstet Gynecol. 1993;1:32-36.
23. Kim JS, Kuk E, Yu KN, etal. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3:95-101.
24. Lok CN, Ho CM, Chen R, etal. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Prot Res. 2006;5:916-924.
25. Morones JR, Elechiguerra JL, Camacho A, etal. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16:2346-2353.
26. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine. 2007;3:168-171.
27. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004;275:177-182.
28. Sun RW, Rong C, Chung NPY, Ho CM, Lin CLS, Che CM. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1infected cells. Chem Commun. 2005;1:5059-5061.
29. Lu L, Sun RW, Chen R, etal. Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther. 2008;13:253-262.
30. Sun L, Singh AK, Vig K, Pillai SR, Singh SR. Silver nanoparticles inhibit replication of respiratory syncytial virus. J Biomed Biotechnol. 2008;4:149-158.
31. Baram-Pinto D, Shukla S, Perkas N, Gedanken A, Sarid R. Inhibition of herpes simplex virus Type 1infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjugate Chem. 2009;20:1497-1502.
32. Rogers JV, Parkinson CV, Choi YW, Speshock JL, Hussain SM. A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation. Nanoscale Res Lett. 2008;3:129-133.
33. Arora S, Jain J, Rajwade JM, Paknikar KM. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett. 2008;179:93-100.
34. Kumari A, Kumar P, Ajayan PM, John G. Silver-nanoparticle-embedded antimicrobial paints based on vegetable oil. Nat Mater. 2008;7: 236-241.
35. Tain J, Wong KK, Ho CM, etal. Topical delivery of silver nanoparticles promotes wound healing. Chem Med Chem. 2007;2:129-136.
36. Sibbald RG, Contreras-Ruiz J, Coutts P, Fierheller J, Rothman A, Woo K. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers. Adv Skin Wound Care. 2007;20:549-558.
37. Wong KK, Cheung SO, Huang L, etal. Further evidence of the anti-inflammatory effects of silver nanoparticles. Chem Med Chem. 2009;4:1129-1135.
38. Gautam A, Dixit S, Philipp MT, etal. Interleukin-10 alters effect functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation. Infect Immun. 2011;79: 4876-4892.
39. Derbigny WA, Kerr MS, Johnson RM. Pattern recognition molecules activated by Chlamydia muridarum infection of cloned murine oviduct epithelial cell lines. J Immunol. 2005;175:6065-6075.
40. Johnson RM. Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect Immun. 2004;72:3951-3960.
41. Gold JA, Parsey M, Hoshino Y, Hoshino S, Nolan A. CD40 contributes to lethality in acute sepsis: in vivo role for CD40in innate immunity. Infect Immun. 2003;71:3521-3528.
42. Ramsey KH, Sigar IM, Schripsema JH, Shaba N, Cohoon KP. Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice. Infect Immun. 2005;73:6962-6973.
43. Grayston JT, Wang SP, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis. 1985;7:717-725.
44. Molestina RE, Miller RD, Ramirez JA, Summersquill JT. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect Immun. 1999;67:1323-1330.
45. Ahamed M, AlSalhi MS, Siddiqui MK. Silver nanoparticles applications and human health. Clin Chim Acta. 2010;411:1841-1848.
46. Paquet P, Piérard GE. Interleukin-6 and the skin. Int Arch Allergy Immunol. 1996;109:308-317.
47. Park HS, Kim KH, Jang S, etal. Attenuation of allergic airway inflammation and hyperresponsivensess in a murine model of asthma by silver nanoparticles. Int J Nanomedicine. 2010;5:505-515.
48. Park HS, Kim KH, Jang S, etal. Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation. Int J Nanomedicine. 2010;7:1329-1343.
49. Sheikpranbabu S, Kalishwaralal K, Venkataraman D, Eom SH, Park J, Gurunathan S. Silver nanoparticles inhibit VEGF-and IL-1-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells. J Nanobiotechnology. 2009;7:8.
50. Lara HH, Ayala-Nunez NV, Ixtepan-Turrent L, Rodriguez-Padilla C. Model of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnology. 2010;8:1.
51. Lee YC, Lee HK. Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol. 2001;107:1106.
52. Nolan A, Kobayashi H, Naveed B, etal. Differential role for CD80 and CD86in the regulation of the innate immune response in murine polymicrobial sepsis. PLoS One. 2009;4:e6600.
53. Orabona C, Grohmann U, Belladonna ML, Fallarino F, Vacca C. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat Immunol. 2004;5:1134-1142.
54. Sharpe AH, Freeman GJ. The B7-CD28superfamily. Nat Rev Immunol. 2002;2:116-126.
55. Grohmann U, Orabona C, Fallarino F, etal. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol. 2002;3:1097-1101.
56. Nolan A, Weiden M, Kelly A, etal. CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis. Am J Respir Crit Care Med. 2008;177:301-308.